CD34 and graft versus host disease: A total of 1 × 106 cells were transplanted into irradiated 4–6-week-old female NOG-EXL (n = 8) mice post T-cell depletion treatment using UCHT1 antibody to prevent GVHD development from any residual T-cell presence post enrichment for CD34+ cells [12].